Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,368.85
(
-1.67%
)
US TECH 100
22,405.20
(
-2.38%
)
Dow Jones
45,166.64
(
-1.73%
)
Brent Oil
106.89
(
0.00%
)
Bitcoin
66,641.84
(
0.48%
)
News Focus
News Focus
Post# of 257302
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

oc631

Send PM Follow Ignore
Followers 15
Posts 1749
Boards Moderated 0
Alias Born 08/12/2007

oc631

Re: genisi post# 137354

Sunday, 02/19/2012 6:05:56 AM

Sunday, February 19, 2012 6:05:56 AM

Post# of 257302

Riba could be too weak in GT1




Right. The market may have been kind to GILD's stock on Friday considering the run-up since the deal was announced.




Either way, replacing Riba with a more potent DAA should help.




Purine nucleotides (using PSI-938 as an example) can be more potent than GS-7977. Since ribavirin's MoA is often compared to a weak purine nucleotide, do you feel this class could make up for the shortcomings of the GS-7977/Riba combination in nulls?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today